Megan Sullivan
Family Medicine · Concord, NHNPI 1336767458
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $989 and has fallen 83.0% since, to $168 in 2024. Among family medicine clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$626
- Lilly USA, LLC$385
- Merck$242
- Novo Nordisk$232
- Pfizer$217
- Biohaven Pharmaceuticals, Inc.$171
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,067100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $626 |
| Lilly USA, LLC | 23 | $385 |
| Merck | 13 | $242 |
| Novo Nordisk | 11 | $232 |
| Pfizer | 16 | $217 |
| Biohaven Pharmaceuticals, Inc. | 10 | $171 |
| Teva Pharmaceuticals USA, Inc. | 8 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $127 |
| Bayer | 6 | $122 |
| Amgen | 5 | $106 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $106 |
| AbbVie | 4 | $94 |
| Ironshore Pharmaceuticals Inc. | 4 | $75 |
| GSK | 4 | $65 |
| Eisai Inc. | 4 | $60 |
| Johnson & Johnson | 3 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Boehringer Ingelheim | 2 | $36 |
| Gilead | 2 | $34 |
| Seqirus USA Inc | 2 | $33 |
| Hologic Sales And Service, LLC | 1 | $30 |
| Corium, LLC | 1 | $21 |
| Abbott | 1 | $21 |
| VBI Vaccine (delaware) Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$3,067 in reported general payments places this provider in the 90th percentile of 397 family medicine providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $13,986 |
| LinzessLinaclotide | 13 | $6,803 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,115 |
| MyrbetriqMirabegron | 12 | $5,339 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,157 |
| Bupropion XlBupropion Hcl | 13 | $855 |
| Duloxetine Hcl | 32 | $808 |
| Pregabalin | 11 | $753 |
| Gabapentin | 56 | $642 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $577 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 12 | $575 |
| Pantoprazole Sodium | 35 | $558 |
| Levothyroxine Sodium | 52 | $543 |
| Fluoxetine Hcl | 14 | $510 |
| Montelukast Sodium | 36 | $500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $217 | $13,98612 claims |
| AbbVieLinzess, Synthroid | $94 | $6,86325 claims |
| Boehringer IngelheimSpiriva Respimat | $36 | $6,11512 claims |
| GSKBreo Ellipta | $65 | $4,15711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 397 family medicine providers in New Hampshire.
Other family medicine in Concord
- Peter LoeserConcord$10K
- Jennifer BadgerConcord$4K
- Mathew SawyerConcord$3K
- Patrick FoxConcord$3K
- Sabrina BolianitesConcord$3K
- Jennifer MackenzieConcord$3K
- Jeffrey CorbettConcord$2K
- Kenneth CallConcord$1K
- Mark BallentynePortsmouth$135K
- M LauterPortsmouth$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.